Trexquant Investment LP Sells 1,363 Shares of Viemed Healthcare, Inc. (NASDAQ:VMD)

Trexquant Investment LP decreased its position in Viemed Healthcare, Inc. (NASDAQ:VMDFree Report) by 10.9% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,174 shares of the company’s stock after selling 1,363 shares during the period. Trexquant Investment LP’s holdings in Viemed Healthcare were worth $88,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. AJOVista LLC bought a new position in Viemed Healthcare in the 4th quarter worth about $42,000. State Board of Administration of Florida Retirement System purchased a new position in Viemed Healthcare in the 3rd quarter worth about $67,000. Ulland Investment Advisors LLC raised its position in Viemed Healthcare by 63.8% in the 4th quarter. Ulland Investment Advisors LLC now owns 20,675 shares of the company’s stock worth $162,000 after buying an additional 8,050 shares during the last quarter. Violich Capital Management Inc. purchased a new position in Viemed Healthcare in the 4th quarter worth about $177,000. Finally, State of New Jersey Common Pension Fund D purchased a new position in Viemed Healthcare in the 4th quarter worth about $189,000. Institutional investors own 74.24% of the company’s stock.

Wall Street Analyst Weigh In

Separately, Lake Street Capital raised Viemed Healthcare to a “strong-buy” rating in a research report on Tuesday, May 7th.

Check Out Our Latest Stock Analysis on Viemed Healthcare

Viemed Healthcare Price Performance

Shares of NASDAQ:VMD opened at $7.55 on Thursday. Viemed Healthcare, Inc. has a fifty-two week low of $5.90 and a fifty-two week high of $10.44. The business has a 50-day simple moving average of $7.83 and a two-hundred day simple moving average of $8.16. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.14 and a current ratio of 1.28. The firm has a market cap of $293.09 million, a price-to-earnings ratio of 29.04 and a beta of 1.49.

Viemed Healthcare (NASDAQ:VMDGet Free Report) last released its quarterly earnings results on Monday, May 6th. The company reported $0.04 EPS for the quarter. Viemed Healthcare had a net margin of 5.32% and a return on equity of 9.32%. The firm had revenue of $50.59 million during the quarter.

About Viemed Healthcare

(Free Report)

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.

See Also

Want to see what other hedge funds are holding VMD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Viemed Healthcare, Inc. (NASDAQ:VMDFree Report).

Institutional Ownership by Quarter for Viemed Healthcare (NASDAQ:VMD)

Receive News & Ratings for Viemed Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viemed Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.